Screener
Crinetics Pharmaceuticals CRNX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| STOCKHOLDERS’ EQUITY | ||
| Preferred stock, $0.001 par; 10,000 shares authorized; no shares issued or outstanding at March 31, 2026 or December 31, 2025 | — | — |
| Common stock and paid-in capital, $0.001 par; 200,000 shares authorized; 105,314 shares issued and outstanding at March 31, 2026; 95,575 shares issued and outstanding at December 31, 2025 | 2,828,204 | 2,407,757 |
| Accumulated other comprehensive (loss) income | (1,254) | 1,865 |
| Accumulated deficit | (1,545,272) | (1,417,427) |
| Stock held in trust | (1,032) | (112) |
| TOTAL STOCKHOLDERS’ EQUITY | 1,280,646 | 992,083 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $1,401,323 | $1,126,257 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Crinetics Pharmaceuticals's total liabilities & equity?
- Crinetics Pharmaceuticals (CRNX) reported total liabilities & equity of $1.4B in Q1 2026.
- How has Crinetics Pharmaceuticals's total liabilities & equity changed year-over-year?
- Crinetics Pharmaceuticals's total liabilities & equity increased by 2.9% year-over-year, from $1.36B to $1.4B.
- What is the long-term trend for Crinetics Pharmaceuticals's total liabilities & equity?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's total liabilities & equity has grown at a 43.8% compound annual growth rate (CAGR), from $183.45M to $1.13B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Crinetics Pharmaceuticals's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude